The N Terminus of the Human α1D-Adrenergic Receptor Prevents Cell Surface Expression

Journal of Pharmacology and Experimental Therapeutics

Volumn 309, Issue 1, 2004, Pages 388-397

  Hague, Chris ^a   Chen, Zhongjian ^a   Pupo, Andre S ^b   Schulte, Nancy A ^b   Toews, Myron L ^c   Minneman, Kenneth P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR NT D; ALPHA 1B ADRENERGIC RECEPTOR NT D; ALPHA 1D ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR NT A; ALPHA 1D ADRENERGIC RECEPTOR NT B; CHIMERIC PROTEIN; GREEN FLUORESCENT PROTEIN; INOSITOL PHOSPHATE; NORADRENALIN; RADIOLIGAND; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CELL FUNCTION; CELL SURFACE; CELL TYPE; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIGAND BINDING; MEMBRANE TRANSPORT; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RAT; RECEPTOR BINDING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

BINDING SITES; CELL MEMBRANE; CELLS, CULTURED; GREEN FLUORESCENT PROTEINS; HUMANS; INOSITOL PHOSPHATES; LUMINESCENT PROTEINS; NOREPINEPHRINE; PROTEIN SORTING SIGNALS; PROTEIN STRUCTURE, TERTIARY; RADIOLIGAND ASSAY; RECEPTORS, ADRENERGIC, ALPHA-1; SUBCELLULAR FRACTIONS; TRANSFECTION;

EID: 1642346628     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.060509     Document Type: Article

References (41)

1. Abbott KL, Robida AM, Davis ME, Pavlath GK, Camden JM, Turner JT, and Murphy TJ (2000) Differential regulation of vascular smooth muscle nuclear factor kappa-B by G alpha q-coupled and cytokine receptors. J Mol Cell Cardiol 32:391-403.
2. Buck LB (2000) The molecular architecture of odor and pheromone sensing in mammals. Cell 100:611-618.
3. Chalothorn D, McCune DF, Edelmann SE, Garcia-Cazarin ML, Tsujimoto G, and Piascik MT (2002) Differences in the cellular localization and agonist-mediated internalization properties of the alpha(1)-adrenoceptor subtypes. Mol Pharmacol 61:1008-1016.
4. Chandrashekar J, Mueller KL, Hoon MA, Adler E, Feng L, Guo W, Zuker CS, and Ryba NJ (2000) T2Rs function as bitter taste receptors. Cell 100:703-711.
5. Chang DJ, Chang TK, Yamanishi SS, Salazar FH, Kosaka AH, Khare R, Bhakta S, Jasper JR, Shieh IS, Lesnick JD, et al. (1998) Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoforms. FEBS Lett. 422:279-283.
6. Chen L, Xin X, Eckhart AD, Yang N, and Faber JE (1995) Regulation of vascular smooth muscle growth by alpha1-adrenoreceptor subtypes in vitro and in situ. J Biol Chem 270:30980-30988.
7. Daunt DA, Hurt C, Hein L, Kallio J, Feng F, and Kobilka BK (1997) Subtype-specific intracellular trafficking of alpha2-adrenergic receptors. Mol Pharmacol 51:711-720.
8. Edwards SW, Tan CM, and Limbird LE (2000) Localization of G-protein-coupled receptors in health and disease. Trends Pharmacol Sci 21:304-308.
9. Esbenshade TA, Hirasawa A, Tsujimoto G, Tanaka T, Yano J, Minneman KP, and Murphy TJ (1995) Cloning of the human alpha 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells. Mol Pharmacol 47:977-985.
10. Graham RM, Perez DM, Hwa J, and Piascik MT (1996) alpha 1-adrenergic receptor subtypes. Molecular structure, function and signaling. Circ Res 78:737-749.
11. Greasley PJ, Fanelli F, Scheer A, Abuin L, Nenniger-Tosato M, DeBenedetti PG, and Cotecchia S (2001) Mutational and computational analysis of the alpha(1b)-adrenergic receptor. Involvement of basic and hydrophobic residues in receptor activation and G protein coupling. J Biol Chem 276:46485-46494.
12. Guan XM, Kobilka TS, and Kobilka BK (1992) Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide. J Biol Chem 267:21995-21998.
13. Hirasawa A, Sugawara T, Awaji T, Tsumaya K, Ito H, and Tsujimoto G (1997) Subtype-specific differences in subcellular localization of alpha1-adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface alpha1-adrenoceptors irrespective of the subtype. Mol Pharmacol 52:764-770.
14. Hussain MB and Marshall I (1997) Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery. Br J Pharmacol 122:849-858.
15. Hussain MB and Marshall I (2000) Alpha(1)-adrenoceptor subtypes mediating contractions of the rat mesenteric artery. Eur J Pharmacol 395:69-76.
16. Kochl R, Alken M, Rutz C, Krause G, Oksche A, Rosenthal W, and Schulein R (2002) The signal peptide of the G protein-coupled human endothelin B receptor is necessary for translocation of the N-terminal tail across the endoplasmic reticulum membrane. J Biol Chem 277:16131-16138.
17. Krautwurst D, Yau KW, and Reed RR (1998) Identification of ligands for olfactory receptors by functional expression of a receptor library. Cell 95:917-926.
18. Mackenzie JF, Daly CJ, Pediani JD, and McGrath JC (2000) Quantitative imaging in live human cells reveals intracellular alpha(1)-adrenoceptor ligand-binding sites. J Pharmacol Exp Ther 294:434-443.
19. McCune DF, Edelmann SE, Olges JR, Post GR, Waldrop BA, Waugh DJ, Perez DM, and Piascik MT (2000) Regulation of the cellular localization and signaling properties of the alpha(1B)- and alpha(1D)-adrenoceptors by agonists and inverse agonists. Mol Pharmacol 57:659-666.
20. Perez DM, DeYoung MB, and Graham RM (1993) Coupling of expressed alpha 1B- and alpha 1D-adrenergic receptor to multiple signaling pathways is both G protein and cell type specific. Mol Pharmacol 44:784-795.
21. Piascik MT, Guarino RD, Smith MS, Soltis EE, Saussy DL Jr, and Perez DM (1995) The specific contribution of the novel alpha-1D adrenoceptor to the contraction of vascular smooth muscle. J Pharmacol Exp Ther 275:1583-1589.
22. Piascik MT and Perez DM (2001) Alpha1-adrenergic receptors: new insights and directions. J Pharmacol Exp Ther 298:403-410.
23. Price RR, Morris DP, Biswas G, Smith MP, and Schwinn DA (2002) Acute agonist-mediated desensitization of the human alpha 1a-adrenergic receptor is primarily independent of carboxyl terminus regulation: implications for regulation of alpha 1aAR splice variants. J Biol Chem 277:9570-9579.
24. Pupo AS, Uberti MA, and Minneman KP (2003) N-Terminal truncation of human alpha(1D)-adrenoceptors increases expression of binding sites but not protein. Eur J Pharmacol 462:1-8.
25. Tanoue A, Koba M, Miyawaki S, Koshimizu TA, Hosoda C, Oshikawa S, and Tsujimoto G (2002a) Role of the alpha1D-adrenegric receptor in the development of salt-induced hypertension. Hypertension 40:101-106.
26. Tanoue A, Nasa Y, Koshimizu T, Shinoura H, Oshikawa S, Kawai T, Sunada S, Takeo S, and Tsujimoto G (2002b) The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J Clin Investig 109:765-775.
27. Theroux TL, Esbenshade TA, Peavy RD, and Minneman KP (1996) Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. Mol Pharmacol 50:1376-1387.
28. Toews M (2000) Radioligand binding assays for G-protein coupled receptor internalization, in Regulation of G-Protein Coupled Receptor Function and Expression (Benovic JL ed) pp 199-230, John Wiley & Sons, Inc., New York.
29. Turnbull L, McCloskey DT, O'Connell TD, Simpson PC, and Baker AJ (2003) Alpha 1-adrenergic receptor responses in alpha 1AB-AR knockout mouse hearts suggest the presence of alpha 1D-AR. Am J Physiol 284:H1104-H1109.
30. Vicentic A, Robeva A, Rogge G, Uberti M, and Minneman KP (2002) Biochemistry and pharmacology of epitope-tagged alpha(1)-adrenergic receptor subtypes. J Pharmacol Exp Ther 302:58-65.
31. Volpicelli LA, Lah JJ, and Levey AI (2001) Rab5-dependent trafficking of the m4 muscarinic acetylcholine receptor to the plasma membrane, early endosomes and multivesicular bodies. J Biol Chem 276:47590-47598.
32. von Zastrow M, Link R, Daunt D, Barsh G, and Kobilka B (1993) Subtype-specific differences in the intracellular sorting of G protein-coupled receptors. J Biol Chem 268:763-766.
33. Wang J, Wang L, Zheng J, Anderson JL, and Toews ML (2000) Identification of distinct carboxyl-terminal domains mediating internalization and down-regulation of the hamster alpha(1B)-adrenergic receptor. Mol Pharmacol 57:687-694.
34. Wang J, Zheng J, Anderson JL, and Toews ML (1997) A mutation in the hamster alpha1B-adrenergic receptor that differentiates two steps in the pathway of receptor internalization. Mol Pharmacol 52:306-313.
35. Wilson KM, Gilchrist S, and Minneman KP (1990) Comparison of alpha 1-adrenergic receptor-stimulated inositol phosphate formation in primary neuronal and glial cultures. J Neurochem 55:691-697.
36. Wozniak M and Limbird LE (1996) The three alpha 2-adrenergic receptor subtypes achieve basolateral localization in Madin-Darby canine kidney H cells via different targeting mechanisms. J Biol Chem 271:5017-5024.
37. Wu D, Katz A, Lee CH, and Simon MI (1992) Activation of phospholipase C by alpha 1-adrenergic receptors is mediated by the alpha subunits of Gq family. J Biol Chem 267:25798-25802.
38. Xia H, von Zastrow M, and Malenka RC (2002) A novel anterograde trafficking signal present in the N-terminal extracellular domain of ionotropic glutamate receptors. J Biol Chem 277:47765-47769.
39. Yang M, Verfurth F, Buscher R, and Michel MC (1997) Is alpha1D-adrenoceptor protein detectable in rat tissues? Naunyn-Schmiedeberg's Arch Pharmacol 355:438-446.
40. Zhong H and Minneman KP (1999a) Alpha1-adrenoceptor subtypes. Eur J Pharmacol 375:261-276.
41. Zhong H and Minneman KP (1999b) Differential activation of mitogen-activated protein kinase pathways in PC12 cells by closely related alpha1-adrenergic receptor subtypes. J Neurochem 72:2388-2396.